Proof of Concept: Oral Heat Shock Protein 90 Inhibitor Shows Promise in HS
Heat shock protein 90 inhibition by oral RGRN-305 may represent a novel way of treating hidradenitis suppurativa (HS), according to a study in JAMA Dermatology. In the parallel-design double-blind trial of 15 HS patients, those patients who received oral RGRN-305, 250 mg, once daily showed a robust treatment response compared with their counterparts who received placebo after […]